Definitive Healthcare introduced its Atlas Dataset, which provides the foundation for the company’s healthcare commercial intelligence and powers Definitive Healthcare’s existing products, analytics, and solutions. The Atlas Dataset ranked first or second in each of the top ten use cases for healthcare reference and affiliation data, according to an independent third-party research survey conducted in November 2022. "Over the last decade, we’ve been recognized as a leader in reference and affiliations data, helping clients gain unique intelligence on healthcare entities. We’re excited to package up all the data that our clients know and love in the Atlas Dataset," said Robert Musslewhite, CEO of Definitive Healthcare. "With the Atlas Dataset, we’re empowering customers to make strategic data-driven decisions based on up-to-date intelligence on the complex and broad healthcare ecosystem."
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on DH:
- Definitive Healthcare greatly expands all-payor medical and prescription claims coverage
- Definitive Healthcare introduces the Atlas Dataset
- Morgan Stanley Pounds the Table on These 2 Beaten-Down Stocks; Sees More Than 50% Upside Ahead
- Definitive Healthcare to Present at the 25th Annual Needham Growth Conference
- Definitive Healthcare price target raised to $15 from $13 at Canaccord
